DLBS 3233 added to clomiphene citrate in women with polycystic ovary syndrome
Tests DLBS 3233 with clomiphene citrate in women with polycystic ovary syndrome.
Plain-language title generated from the registry record
Registry title: The Effect of Therapy Combination in PCOS With Dlbs 3233
Key facts
- Where
- Yogyakarta, IndonesiaSee the site
- Phase
- Early phase 1
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for married women with polycystic ovary syndrome (PCOS) who agree to join. It compares dlbs 3233 plus clomifen citrate with clomifen citrate alone.
- Age
- Up to 45 years.
- Sex
- Women only.
Main reasons for not taking part
- Women who do not agree to join the research
Read by machine on 12 November 2026.
Where in Indonesia
- RS AMC YogyakartaYogyakarta, IndonesiaContact: rs amc yogyakartaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Inlacinpenelitian
- Trial code
- NCT07403201
- Record updated
- 11 February 2026
- Original description
The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center HospitalRead full original descriptionShow less
The Effect of Combination Therapy Dlbs 3233 and Clomifen Citrate vs Clomifen Citrate on Homa ir, Maturation Follicle, and Menstrual Cycle in PCOS Cases at Muhammadiyah Asri Medical Center Hospital
The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital
Inclusion: married agree to join this research.
Exclusion: dis agree to join research.